Biotechnology Company Reports and Industry Analysis
Looking for up-to-date information on leading biotechnology companies worldwide? MarketResearch.com provides an extensive collection of company profile reports that offer in-depth insights into a company's organizational set-up and key offerings within the biotech industry. These reports serve as valuable resources for identifying prospective clients and partners, as well as gaining a deeper insight into the strengths and vulnerabilities of competitors.
Biotechnology Company Profiles
- Gain expert insights on prominent competitors like Amgen, Roche, Biogen, Gilead Sciences, AstraZeneca, and Pfizer, and more.
- Quickly obtain revenue breakdowns, strategic analysis, and future growth outlooks to inform your own strategies.
- Browse reports from various research firms including GlobalData, MarketLine, Plunkett Research, Current Partnering, and Worldwide Videotex.
Why Choose MarketResearch.com as Your Partner
Whether you are an experienced industry professional looking to improve your strategies, a consultant guiding clients on their next steps, or a busy executive tasked with critical decisions, MarketResearch.com's biotechnology company reports can be your guide in this dynamic landscape. Your competitors are also seeking opportunities, but with insights from MarketResearch.com, you can gain a powerful advantage.
Biotechnology Company Reports Industry Research & Market Reports
-
Advanced Marker Discovery SL - Product Pipeline Analysis, 2023 Update
... that support the physician’s decisions about patient management. Amadix provides discovery, clinical validation, assay development, clinical utility, commercialization, in licensing and out licensing services. The company identifies, evaluates and in-licenses breakthrough discoveries in cancer diagnosis ... Read More
-
ClearNote Health - Product Pipeline Analysis, 2023 Update
... cancer development. ClearNote non-invasive liquid biopsy technologies detect changes in specific organs, identify biological activity and gene expression, improve therapy selection and safety monitoring and evaluate individual’s organ systems and biological functions. It also carries ... Read More
-
Altoida Inc - Product Pipeline Analysis, 2023 Update
... Alzheimer's at early stages. Its platform uses smartphone and tablet sensors for measuring neurocognitive domains. The company works in collaboration with therapeutics and research companies such as Novartis, Takeda, Lilly, Eisai, and Click Therapeutics, among ... Read More
-
CPSI Biotech - Product Pipeline Analysis, 2023 Update
... support of diverse clinical and research applications, devices and intellectual property for commercialization ventures among others. Its products find their application in cancer, cardiovascular disease treatments and cell therapy bioprocessing. CPSI is headquartered in Owego, ... Read More
-
Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2023 Update
... to work in three coordinated regions: diagnostics, logical services and medication revelation. Proteomics is the large-scale mapping of the structure and function of proteins. The company created PromarkerD, a prescient test for the determination of ... Read More
-
Locate Bio Ltd - Product Pipeline Analysis, 2023 Update
... infections. Locate provides clinical treatments throughout the body including orthopedic medicine, cell therapy, drug delivery, cell culture and veterinary medicine. The company promotes activities of receptor-binding moieties, locally applied drugs, and emergent biological and cell-based ... Read More
-
C2N Diagnostics LLC - Product Pipeline Analysis, 2023 Update
... and assessment of neurodegenerative disorders. It offers products such as SILK-Ab and SISAQ-Ab assays. C2N Diagnostics' products are used for the measurement of kinetics, or in vivo metabolism, and absolute quantitation of brain derived proteins. ... Read More
-
The 2025-2030 World Outlook for Plant Growth Regulators
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Worldwide Biotech March 2024
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Biotech Financial Reports March 2024
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements. Read More
-
Sera Prognostics Inc (SERA) - Product Pipeline Analysis, 2023 Update
... of premature birth risk for clinicians, mothers and doctors to deliver personalized care plans and treatments for improving the newborn and maternal health. The company’s biomarker pregnancy pipeline includes preeclampsia, molecular time-to-birth, gestational diabetes mellitus ... Read More
-
Worldwide Biotech February 2024
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Amgen, Inc. (AMGN:NASD) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
... Summary Amgen, Inc. (AMGN:NASD) Strategic SWOT, PESTLE, Value Chain Analysis and Financial Insight - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends ... Read More
-
Biotech Financial Reports February 2024
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements. Read More
-
Oncternal Therapeutics, Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Oncternal Therapeutics, Inc. (Oncternal Therapeutics or 'the company') produces and markets diverse pipeline of product candidates for ... Read More
-
Charles River Laboratories International, Inc. - Company Profile and SWOT Analysis
... the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Charles River Laboratories International, Inc. (CRL or 'the company') is a full service, ... Read More
-
Acorda Therapeutics, Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Acorda Therapeutics, Inc. (Acorda or 'the company') is involved in the identification, development and commercialization of novel ... Read More
-
Agilent Technologies, Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Agilent Technologies, Inc. (Agilent or the company) offers instruments, software, services, and consumables solutions to identify, analyze ... Read More
-
Celldex Therapeutics, Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Celldex Therapeutics, Inc. (Celldex or 'the company') is a biopharmaceutical company that develops therapeutic monoclonal and bispecific ... Read More
-
Novartis AG - Company Profile and SWOT Analysis
... product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Novartis AG (Novartis or ‘the company’) manufactures, and supplies pharmaceutical products, and generic and biosimilar medicines. The company’s product ... Read More
-
Kyowa Kirin Co. Ltd. - Company Profile and SWOT Analysis
... structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Kyowa Kirin Co. Ltd (Kyowa Kirin or 'the company'), a subsidiary of Kirin Holdings Company ... Read More
-
United Therapeutics Corporation - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and ... Read More
-
2024 Samsung Biologics Performance, Capabilities, Goals and Strategies
... insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures Marketing tactics Financial results Strengths and weaknesses Strategic directions The objectives of ... Read More
-
2024 Wuxi Biologics Performance, Capabilities, Goals and Strategies
... insight critical to the development and implementation of effective marketing and R&D programs, including: - Latest organizational and management developments Acquisitions and divestitures Marketing tactics Financial results Strengths and weaknesses Strategic directions The objectives of ... Read More
-
International Stem Cell Corp (ISCO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for International Stem Cell Corp (ISCO:PINX) compared to its top competitors and compared to the average for all companies within its primary ... Read More
Research Assistance
